Compare Abeona Therapeutics Inc (ABEO) vs United States Brent Oil Fund LP (BNO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs United States Brent Oil Fund LP — how do they compare? Abeona Therapeutics Inc trades at $6.77 (market cap $373.32M), while United States Brent Oil Fund LP trades at $43.34. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, United States Brent Oil Fund LP nearer its low. Which is the better fit depends on your goals.
| ABEO | BNO | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Commodities - Energy |
52-Week High | $7.23 | $60.13 |
52-Week Low | $4.17 | $27.20 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
BNO trades at $39.94, up 0.68% on the day, amid a bearish technical backdrop with moving averages signaling caution and oscillators neutral. Recent news highlights oil price volatility driven by Middle East tensions and supply disruptions, though fundamental financial ratios are unavailable. The stock faces resistance near $40 with support at $39.
The outlook remains clouded by geopolitical risks and oil market volatility, with limited fundamental data. Upside depends on sustained oil price recovery, but downside risks from supply surges or demand weakness persist. Investors should weigh technical bearishness against external catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About United States Brent Oil Fund LP
BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →
